No Data
Shenzhen New Industries Biomedical Engineering's H1 Profit Jumps 20%, Operating Income Up 19%
ShenZhen New Industries Biomedical Engineering: Summary of Half-Year Report in 2024.
ShenZhen New Industries Biomedical Engineering: Half-year report for the year 2024.
Shenzhen New Industries Biomedical Engineering (300832.SZ): net income in the first half of the year was 0.903 billion yuan, a year-on-year increase of 20.42%.
On August 22, Gelonghui announced its interim report for the first half of 2024, with a revenue of 2.211 billion yuan, an increase of 18.54% compared to the same period last year; a net income of 0.903 billion yuan attributable to shareholders of the listed company, an increase of 20.42% compared to the same period last year; a net income of 0.868 billion yuan attributable to shareholders of the listed company after deducting non-recurring gains and losses, an increase of 26.36% compared to the same period last year; and a basic earnings per share of 1.1495 yuan.
Express News | Shenzhen New Industries Biomedical Says H1 Net Profit up 20.4% Y/Y
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Antiphospholipid Assay Kit
Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Share Price Not Quite Adding UpNo Data
